Evolent Health (EVH) Reports In-Line Q4 EPS; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
Evolent Health (EVH) PT Raised to $63 at Cowen
February 23, 2023 1:04 PM ESTCowen analyst Charles Rhyee raised the price target on Evolent Health (NYSE: EVH) to $63.00 (from $59.00) while maintaining a Outperform rating following results.
The analyst commented, "EVH reported adj. EBITDA and revenue above cons. and introduced 2023 guide (adj. EBITDA of $180M-$200M) that was... More
